Spots Global Cancer Trial Database for collecting duct carcinoma

Every month we try and update this database with for collecting duct carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma	NCT01185366	Kidney Cancer	Everolimus Sunitinib	18 Years -	M.D. Anderson Cancer Center
Collecting Ducts Carcinoma: in Depth Exploration and Biologically Driven Therapy (CICERONE)	NCT05372302	Collecting Duct...		18 Years - 85 Years	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer	NCT04603365	Clear Cell Papi... Collecting Duct... Hereditary Leio... Hereditary Papi... Metastatic Rena... Metastatic Uncl... Papillary Renal... Stage III Renal... Stage IV Renal ... Tubulocystic Re... Unresectable Re...	Pamiparib Temozolomide	18 Years -	Jonsson Comprehensive Cancer Center
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma	NCT06302569	Bellini Carcino... Collecting Duct... Renal Medullary...	Pembrolizumab +...	18 Years -	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors	NCT03866382	Bladder Adenoca... Bladder Clear C... Bladder Mixed A... Bladder Neuroen... Bladder Small C... Bladder Squamou... Chromophobe Ren... Collecting Duct... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Invasive Bladde... Kidney Medullar... Large Cell Neur... Malignant Testi... Malignant Testi... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Blad... Metastatic Chro... Metastatic Kidn... Metastatic Mali... Metastatic Papi... Metastatic Peni... Metastatic Pros... Metastatic Sarc... Metastatic Uret... Papillary Renal... Sarcomatoid Ren... Stage IV Bladde... Stage IV Penile... Stage IV Renal ... Stage IV Urethr... Stage IVB Prost... Urachal Adenoca... Urethral Clear ...	Bone Scan Cabozantinib S-... Computed Tomogr... Ipilimumab Magnetic Resona... Nivolumab Positron Emissi...	18 Years -	National Cancer Institute (NCI)
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study	NCT04071223	Advanced Renal ... Chromophobe Ren... Clear Cell Rena... Collecting Duct... Kidney Medullar... Metastatic Mali... Papillary Renal... Stage IV Renal ... Unclassified Re...	Cabozantinib S-... Quality-of-Life... Questionnaire A... Radium Ra 223 D...	18 Years -	National Cancer Institute (NCI)
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma	NCT06302569	Bellini Carcino... Collecting Duct... Renal Medullary...	Pembrolizumab +...	18 Years -	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: